STEIN-GOLD, L.; ELEWSKI, B.; DRAELOS, Z.; LIN, T. Safety and Efficacy of a Fixed Combination Halobetasol Propionate 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion in the Treatment of Females With Moderate-to-Severe Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 1, p. S9, 2020. Disponível em: https://www.jofskin.org/index.php/skin/article/view/822. Acesso em: 30 jun. 2022.